Catalent vs Charles River Laboratories: CDMO Comparison
Side-by-side comparison of Catalent and Charles River Laboratories on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Catalent →
76.5
Somerset, NJ (now Novo Holdings)
Signal Score
76/100
Quality (FDA + GMP)
79/100
FDA inspections
10
— NAI / VAI / OAI
3 / 6 / 1
FDA warning letters
2
EMA GMP certificates (active)
14
MHRA GMP certificates (compliant)
16
Clinical programs (matched)
0
Capacity
—
Modalities
AAV, CAR-T, Lentiviral, Plasmid DNA
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score
92/100
Quality (FDA + GMP)
99/100
FDA inspections
7
— NAI / VAI / OAI
4 / 3 / 0
FDA warning letters
0
EMA GMP certificates (active)
9
MHRA GMP certificates (compliant)
2
Clinical programs (matched)
0
Capacity
Limited
Modalities
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
Evaluating Catalent and Charles River Laboratories for a program?
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.